Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review

<p>Abstract</p> <p>There are likely many scenarios and pathways that can lead to metabolic syndrome. This paper reviews mechanisms by which the accumulation of visceral adipose tissue (VAT) may contribute to the metabolic syndrome, and explores the paradigm of a critical VAT thresh...

Full description

Bibliographic Details
Main Author: Freedland Eric S
Format: Article
Language:English
Published: BMC 2004-11-01
Series:Nutrition & Metabolism
Online Access:http://www.nutritionandmetabolism.com/content/1/1/12
id doaj-ffc53449822647878c0bcb8b3e84d652
record_format Article
spelling doaj-ffc53449822647878c0bcb8b3e84d6522020-11-25T00:41:11ZengBMCNutrition & Metabolism1743-70752004-11-01111210.1186/1743-7075-1-12Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewFreedland Eric S<p>Abstract</p> <p>There are likely many scenarios and pathways that can lead to metabolic syndrome. This paper reviews mechanisms by which the accumulation of visceral adipose tissue (VAT) may contribute to the metabolic syndrome, and explores the paradigm of a critical VAT threshold (CVATT). Exceeding the CVATT may result in a number of metabolic disturbances such as insulin resistance to glucose uptake by cells. Metabolic profiles of patients with visceral obesity may substantially improve after only modest weight loss. This could reflect a significant reduction in the amount of VAT relative to peripheral or subcutaneous fat depots, thereby maintaining VAT below the CVATT. The CVATT may be unique for each individual. This may help explain the phenomena of apparently lean individuals with metabolic syndrome, the so-called metabolically normal weight (MONW), as well as the obese with normal metabolic profiles, i.e., metabolically normal obese (MNO), and those who are "fit and fat." The concept of CVATT may have implications for prevention and treatment of metabolic syndrome, which may include controlling dietary carbohydrates. The identification of the CVATT is admittedly difficult and its anatomical boundaries are not well-defined. Thus, the CVATT will continue to be a work in progress.</p> http://www.nutritionandmetabolism.com/content/1/1/12
collection DOAJ
language English
format Article
sources DOAJ
author Freedland Eric S
spellingShingle Freedland Eric S
Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
Nutrition & Metabolism
author_facet Freedland Eric S
author_sort Freedland Eric S
title Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
title_short Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
title_full Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
title_fullStr Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
title_full_unstemmed Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
title_sort role of a critical visceral adipose tissue threshold (cvatt) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
publisher BMC
series Nutrition & Metabolism
issn 1743-7075
publishDate 2004-11-01
description <p>Abstract</p> <p>There are likely many scenarios and pathways that can lead to metabolic syndrome. This paper reviews mechanisms by which the accumulation of visceral adipose tissue (VAT) may contribute to the metabolic syndrome, and explores the paradigm of a critical VAT threshold (CVATT). Exceeding the CVATT may result in a number of metabolic disturbances such as insulin resistance to glucose uptake by cells. Metabolic profiles of patients with visceral obesity may substantially improve after only modest weight loss. This could reflect a significant reduction in the amount of VAT relative to peripheral or subcutaneous fat depots, thereby maintaining VAT below the CVATT. The CVATT may be unique for each individual. This may help explain the phenomena of apparently lean individuals with metabolic syndrome, the so-called metabolically normal weight (MONW), as well as the obese with normal metabolic profiles, i.e., metabolically normal obese (MNO), and those who are "fit and fat." The concept of CVATT may have implications for prevention and treatment of metabolic syndrome, which may include controlling dietary carbohydrates. The identification of the CVATT is admittedly difficult and its anatomical boundaries are not well-defined. Thus, the CVATT will continue to be a work in progress.</p>
url http://www.nutritionandmetabolism.com/content/1/1/12
work_keys_str_mv AT freedlanderics roleofacriticalvisceraladiposetissuethresholdcvattinmetabolicsyndromeimplicationsforcontrollingdietarycarbohydratesareview
_version_ 1725286823999045632